How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,042 results for

Deep Vein Thrombosis of the Upper Extremity

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Superficial Venous Thrombosis

Overview of Aneurysms SOCIAL MEDIA Add to Any Platform Loading , MD, McMaster University Click here for Patient Education NOTE: This is the Professional Version. CONSUMERS: Superficial venous thrombosis is a blood clot in a superficial vein of the upper or lower extremities or, less commonly, in one or more veins of the chest or breast (Mondor disease). Superficial venous thrombosis in the upper extremity most commonly results from IV infusions or catheterization; varicose veins seem to be the main (...) risk factor for the lower extremity, especially among women. Superficial venous thrombi rarely cause serious complications and rarely become emboli. Typically, patients present with pain, tenderness, or an indurated cord along a palpable superficial vein. The overlying skin is usually warm and erythematous. Migratory superficial venous thrombosis, which develops, resolves, and recurs in normal veins of the arms, legs, and torso at various times, is a possible harbinger of pancreatic cancer

2013 Merck Manual (19th Edition)

162. Lower-Extremity Edema During Late Pregnancy

measurement Urine protein measurement CBC, electrolytes, BUN, glucose, creatinine, liver function tests Cellulitis Tender unilateral swelling in a leg or calf, erythema (asymmetric), warmth, and sometimes fever Manifestations often more circumscribed than in DVT Ultrasonography to rule out DVT unless swelling is clearly localized Examination for source of infection DVT = deep venous thrombosis. Evaluation Evaluation aims to exclude DVT and preeclampsia. Physiologic edema is a diagnosis of exclusion (...) for evidence of fluid overload (eg, audible S 3 or S 4 heart sounds, tachypnea, rales, crackles) and inspection of neck veins for jugular venous distention. The abdomen should be palpated for tenderness, especially in the epigastric or right upper quadrant region. Neurologic examination should assess mental status for confusion and seek focal neurologic deficits. Red flags The following findings are of particular concern: BP ≥ 140/90 mm Hg Unilateral leg or calf warmth, redness, or tenderness

2013 Merck Manual (19th Edition)

163. Rosuvastatin for Preventing Deep Vein Thrombosis

: Development of deep vein thrombosis diagnosed and confirmed by CT angiography at lower extremities [ Time Frame: 7days after index surgery ] Secondary Outcome Measures : D-dimer, lipid panel (Total cholesterol, TG, HDL, LDL), hsCRP, CK, transaminase, ALP [ Time Frame: 7days, 1month, 2month after index surgery ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members (...) Rosuvastatin for Preventing Deep Vein Thrombosis Rosuvastatin for Preventing Deep Vein Thrombosis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Rosuvastatin for Preventing Deep Vein Thrombosis (STOP-DVT

2009 Clinical Trials

164. Thrombosis

vessel or the organ supplied by it. Venous thrombosis [ ] Main article: Deep vein thrombosis [ ] Main article: Deep vein thrombosis (DVT) is the formation of a blood clot within a . It most commonly affects leg veins, such as the . Three factors are important in the formation of a blood clot within a deep vein—these are the rate of blood flow, the thickness of the blood and qualities of the vessel wall. Classical signs of DVT include , pain and redness of the affected area. [ ] Paget-Schroetter (...) [ ] Main article: Hypercoagulability or thrombophilia , is caused by, for example, or . Recent studies indicate that white blood cells play a pivotal role in deep vein thrombosis, mediating numerous pro-thrombotic actions. Endothelial cell injury [ ] Any inflammatory process, such as trauma, surgery or infection, can cause damage to the of the vessel's wall. The main mechanism is exposure of to the blood coagulation system. Inflammatory and other stimuli (such as ) can lead to changes in in endothelium

2012 Wikipedia

165. HemaClear for bloodless surgical field during limb surgery

) patients having endoscopic procedures (for example, endoscopic carpal tunnel release). Surgeons should use HemaClear with the help of nurses or other operating theatre staff. Because of its effect on the cardiovascular system, anaesthetists should also be involved. The company states that the device should not be used in patients with an existing deep vein thrombosis, poor peripheral blood flow, oedema, an infected limb or limb with malignancy. It should also not be used directly on fragile skin (...) to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 6 of 15Despite being contraindicated in patients with a known deep vein thrombosis, there are still concerns about use in patients who may be at risk of developing a venous thromboembolism. A case report by Feldman et al. (2015) showed 2 patients with traumatic injuries who developed pulmonary emboli after using HemaClear, 1 of which was fatal. They suggest caution in using the device and highlight a safety

2019 National Institute for Health and Clinical Excellence - Advice

166. Recommendations for good practice in Ultrasound: Oocyte retrieval

are shorter in comparison with general anaesthesia (Piroli et al., 2012). Therefore, OPU under conscious sedation is usually a suitable option for patients and operators alike (Kwan et al., 2018). Patient selection is an important consideration. Although conscious sedation is a well-tolerated option for most patients, in some circumstances deep sedation could be preferable such as in cases of: • Extreme anxiety; • Associated pathologies than can complicate OPU, making the procedure longer or painful (...) where there was the development of only a few follicles and/or when there are concerns of premature ovulation, transvaginal ultrasound should be performed before starting the procedure. Patient position and preparation for the procedure - The patient must fast, 6 h for food and 2 h for clear fluids (see also section sedation) - A peripheral intravenous line should be established, with Ringer’s lactate solution or physiological saline solution at the minimum speed required in order to keep the vein

2019 European Society of Human Reproduction and Embryology

167. Pregnancy and Renal Disease

: Weight management before, during and after pregnancy [PH27], 2010 [additional data from 2017 surveillance available at: https://www.nice.org.uk/guidance/ph11/evidence/appendix-a-summary-of- evidence-from-surveillance-pdf-4671107966] ? NICE: Hypertension in Pregnancy: Diagnosis and Management [CG107], 2011 (update awaited 2019). ? UK Renal Association Clinical Practice Guidelines: Undernutrition in Chronic Kidney Disease, June 2019 ? RCOG: Thrombosis and Embolism During Pregnancy and the Puerperium (...) /mmol) be offered thromboprophylaxis with low molecular weight heparin in pregnancy and the post-partum period unless there is a specific contraindication including risk of labour or active bleeding (1D). Renal Association Clinical Practice Guideline Pregnancy and Renal Disease – September 2019 12 Guideline 4.5.2 We suggest that non-nephrotic range proteinuria in pregnancy is a risk factor for thrombosis and thromboprophylaxis with low molecular weight heparin should be considered in the presence

2019 Renal Association

168. Guidelines on Supraventricular Tachycardia (for the management of patients with)

PRKAG2 Protein kinase AMP-activated non-catalytic subunit gamma 2 PV Pulmonary vein RA Right atrial/anterior RAS Right anteroseptal RBBB Right bundle branch block RCT Randomized clinical trial RL Right lateral RP Right posterior RPS Right posteroseptal RyR Sarcoplasmic reticulum Ca2+ channel SPERRI Shortest pre-excited RR interval during atrial fibrillation SR Sarcoplasmic reticulum SVT Supraventricular tachycardia TA Triggered activity TCM Tachycardiomyopathy TDI Tissue Doppler imaging VA (...) or younger is less likely to have AT or AF continuing into adulthood. Such a long history will point towards a re-entrant mechanism. Dyspnoea, or other clinical signs and symptoms of HF, can occur when the patient has developed TCM. Light-headedness in association with SVT is not infrequent. Presyncope and syncope are less common, , and tend to be associated with presentation in older individuals. In older patients, symptoms may be more extreme—with dizziness, presyncope, and syncope—in view of the less

Full Text available with Trip Pro

2019 European Society of Cardiology

169. Diagnosis and Management of Acute Pulmonary Embolism

weeks post-partum 38 Figure 8 Follow-up strategy and diagnostic workup for long-term sequelae of pulmonary embolism 44 Abbreviations and acronyms AcT Right ventricular outflow Doppler acceleration time AFE Amniotic fluid embolism ALT Alanine aminotransferase AMPLIFY Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-line Therapy ASPIRE Aspirin to Prevent Recurrent Venous Thromboembolism trial AV Arteriovenous b.i.d Bis in die (twice a day) BNP B-type (...) CYP3A4 Cytochrome 3A4 DAMOVES D-dimer, Age, Mutation, Obesity, Varicose veins, Eight [coagulation factor VIII], Sex DASH D-dimer, Age, Sex, Hormonal therapy DVT Deep vein thrombosis ECMO Extracorporeal membrane oxygenation ELISA Enzyme-linked immunosorbent assay EMA European Medicines Agency ERS European Respiratory Society ESC European Society of Cardiology FAST H-FABP, Syncope, Tachycardia (prognostic score) FDA US Food and Drug Administration GUSTO Global Utilization of Streptokinase and Tissue

Full Text available with Trip Pro

2019 European Society of Cardiology

170. VTE prophylaxis

contraceptive pills and HRT, varicose veins, pregnancy and up to 6 week postnatal, first-degree relative with a history of VTE, extended travel, and admission to intensive care previous VTE (deep vein thrombosis [DVT] and/or pulmonary embolism [PE]) thrombophilia malignancy postoperative setting trauma indwelling central catheter (upper or lower extremity) immobility myeloproliferative diseases congestive heart failure chronic obstructive pulmonary disease inflammatory bowel disease neurological disease (...) and 60% to 75% of surgical patients receive adequate thromboprophylaxis. Computer-based decision systems and pre-printed orders are most effective in optimising physician adherence to thromboprophylaxis guidelines. Periodic audits by pharmacists or other health professionals reinforce the consistent use of venous thromboembolism prophylaxis. Definition Venous thromboembolism (VTE) prophylaxis consists of pharmacological and non-pharmacological measures to diminish the risk of deep vein thrombosis

2018 BMJ Best Practice

171. Bariatric surgery: an HTA report on the efficacy, safety and cost-effectiveness

SGastro oesophagal reflux Urinary incontinence Osteoarthritis Varicose veins Increased peripheral steroid interconversion in adipose tissue Hormone-dependent cancers (breast, uterus) Male hypogonadism Influence on polycystic ovarian syndrome or PCOS (infertility, hirsutism) Others Psychological morbidity / psychosocial impact (low self-esteem, body image disorder, depression, social isolation and stigmatisation) Socioeconomic disadvantage (lower income, un-employment, less likely to be promoted (...) and lifestyle modifications, there is increasing interest in performing MBS in adolescents with severe or morbid obesity, especially in those at very high risk or those with associated co- morbidities like hypertension, diabetes and non-alcoholic steatohepatitis (NASH), as well as in those with extreme BMI values, who cannot be managed successfully otherwise. A particular medical challenge constitute children and adolescents with monogenic traits causing morbid or super- obesity. Psychopathology and social

2019 Belgian Health Care Knowledge Centre

173. Management of Stroke in Neonates and Children

thrombosis (CSVT) or cortical vein thrombosis. In CSVT, occlusion of venous sinuses may or may not be accompanied by hemorrhage. In older infants and children, some literature uses the term silent stroke when asymptomatic infarcts are found on neuroimaging. However, this is a misnomer because the definition of stroke includes a clinical event; we use the term silent infarct in this review. However, silent infarcts are likely not truly silent; as in adults, a sufficient burden likely causes vascular (...) of antithrombotic agents. Perinatal Stroke Perinatal stroke includes both ischemic and hemorrhagic events resulting from disruption of either arteries or veins from early gestation through the first month of life. We have chosen to use the term perinatal rather than neonatal for consistency, although both terms are found in the literature. Perinatal stroke is sometimes defined as a stroke that occurs from 28 weeks’ gestation through the first 7 days of life. Other authors have expanded this interval from 20

Full Text available with Trip Pro

2019 American Heart Association

174. Heart Disease and Stroke Statistics

Cardiac Arrest, Ventricular Arrhythmias, and Inherited Channelopathies e377 18. Subclinical Atherosclerosis e401 19. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris e415 20. Cardiomyopathy and Heart Failure e438 21. Valvular Diseases e455 22. Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism), Chronic Venous Insufficiency, Pulmonary Hypertension e472 23. Peripheral Artery Disease and Aortic Diseases e481 Outcomes 24. Quality of Care e497 25. Medical Procedures (...) disease. Admissions for endocarditis related to injection drug use have risen in recent years in parallel with the opioid drug crisis. The prevalence of documented intravenous drug use among people admitted to a hospital because of endocarditis in the National (Nationwide) Inpatient Sample rose from 4.3% in 2008 to 10% in 2014. Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism), Chronic Venous Insufficiency, Pulmonary Hypertension (Chapter 22) Traditional atherosclerotic risk factors

Full Text available with Trip Pro

2019 American Heart Association

175. Vascular imaging

/hemorrhage – abdominal aorta and/or branch vessel 20 Mesenteric ischemia 20 Portal hypertension 21 Pseudoaneurysm – abdominal aorta or branch vessel 21 Renal artery stenosis 21 Stenosis or occlusion of the abdominal aorta or branch vessels 21 Unexplained blood loss in the abdomen or pelvis 22 Venous thrombosis or occlusion 22 Visceral artery aneurysm 22 Upper Extremity 22 Steno-occlusive disease 22 Other vascular indications in upper extremity 22 Lower Extremity 23 Peripheral arterial disease – lower (...) or MRA brain Venous thrombosis or compression – extracranial Advanced imaging is considered medically necessary when the results of imaging are essential to establish a diagnosis and/or direct management. IMAGING STUDY - CTA or MRA neck Venous thrombosis or compression – intracranial Includes dural venous sinus thrombosis, venous sinus thrombosis, and cerebral vein thrombosis ADULT Advanced imaging is considered medically necessary for management of known venous thrombosis and for diagnosis based

2019 AIM Specialty Health

176. DVT

contact us via jon.brassey@tripdatabase.com Top results for dvt 1. DVT prevention for travellers DVT prevention for travellers - NICE CKS Clinical Knowledge Summaries Share DVT prevention for travellers - Summary Deep vein thrombosis ( DVT ) can occur as a result of long distance travel. The risk of travel-related DVT in healthy people is extremely low, and increases with the duration of travel — the risk has been reported as 1 event per 4656 flights lasting over 4 hours, increasing to 1 event per (...) venous thrombosis ( DVT ) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions that impair venous return, lead to endothelial injury or dysfunction, or cause hypercoagulability. DVT may be asymptomatic or cause pain and swelling in an extremity; pulmonary embolism is an immediate 2013 14. Systematic review: A low Wells score and a negative D-dimer was not safe in patients with cancer

2018 Trip Latest and Greatest

178. ESC/ESH Management of Arterial Hypertension

8.17 Hypertension and vascular disease3088 8.17.1 Carotid atherosclerosis3088 8.17.2 Arteriosclerosis and increased arterial stiffness3088 8.17.3 Lower extremity arterial disease3089 8.18 Hypertension in valvular disease and aortopathy3089 8.18.1 Coarctation of the aorta3089 8.18.2 Prevention of aortic dilation and dissection in high-risk subjects3089 8.18.3 Hypertension bicuspid aortic valve-related aortopathy3089 8.19 Hypertension and sexual dysfunction3089 8.20 Hypertension and cancer (...) Rosuvastatin LDH Lactate dehydrogenase LDL-C LDL cholesterol LEAD Lower extremity artery disease LIFE Losartan Intervention For Endpoint reduction in hypertension LV Left ventricular LVH Left ventricular hypertrophy MAP Mean arterial pressure MI Myocardial infarction MR Magnetic resonance MRA Mineralocorticoid receptor antagonist MRI Magnetic resonance imaging MUCH Masked uncontrolled hypertension NORDIL Nordic Diltiazem NS Non-significant NT-proBNP N-terminal pro-B natriuretic peptide o.d. Omni die (every

Full Text available with Trip Pro

2018 European Society of Cardiology

179. ESC/EACTS Guidelines on Myocardial Revascularization

for saphenous vein graft lesions 125 13.4 Repeat percutaneous coronary intervention 125 13.4.1 Restenosis 125 13.4.2 Disease progression 126 13.4.3 Stent thrombosis 126 14 Arrhythmias 127 14.1 Ventricular arrhythmias 127 14.1.1 Revascularization for the prevention of sudden cardiac death in patients with stable coronary artery disease and reduced left ventricular function 127 14.1.2 Revascularization for the treatment of electrical storm 128 14.1.3 Revascularization after out-of-hospital cardiac arrest 128 (...) harvesting 130 15.1.5 Saphenous vein harvesting 130 15.1.6 Construction of central anastomosis 131 15.1.7 Intraoperative quality control 131 15.1.8 On-pump and off-pump procedures 131 15.1.9 Minimally invasive and hybrid procedures 131 15.2 Reporting perioperative outcomes 131 15.3 Gaps in the evidence 131 16 Procedural aspects of percutaneous coronary intervention 133 16.1 Percutaneous coronary intervention devices 133 16.1.1 Balloon angioplasty 133 16.1.2 Choice of coronary stents 133 16.1.3

Full Text available with Trip Pro

2018 European Society of Cardiology

180. Nonatherosclerotic Peripheral Arterial Disease

Review Introduction/Background Lower-extremity vascular diseases span a diverse range of etiologies and may be autoimmune, congenital, degenerative, inflammatory, infectious, metabolic, neoplastic, or traumatic in nature. Examples of such conditions include, but are not limited to, aneurysm formation, atherosclerosis, Buerger disease, cystic adventitial disease, dissection/transection, deep vein thrombosis, external iliac artery endofibrosis (EIAE), fibromuscular dysplasia (FMD), popliteal arterial (...) throughout the lower extremities may result in varying degrees of stenosis or occlusion and is most often multifocal [9,10]. Varicose veins and deep vein thrombosis are common venous diseases of the lower extremities, with deep vein thrombosis having an estimated annual incidence of 5 per 10,000 in the general population [11]. Guidelines addressing lower-extremity atherosclerotic vascular disease and deep vein thrombosis have been addressed in previously published ACR Appropriateness Criteria ®

2019 American College of Radiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>